Briefly, PB samples were taken from 298 patients with CLL and 166 patients with non-CLL and analyzed using the five standard markers (CD5, CD22, CD23, FMC7, and Slg), together with the SN8 monoclonal antibody, using flow cytometry. This evidence concerns the gene CD22 and B-cell chronic lymphocytic leukemia.